EATG » Comorbidities

Comorbidities

Combination therapy found to be more effective in treating patients with leishmaniasis and HIV

The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières (MSF), the University of Gondar, and Addis Ababa University, open…

HIV and schistosomiasis programmes should be combined to reduce the spread of HIV

Testing and treatment programmes for HIV and schistosomiasis (also known as snail fever or bilharzia) could be profitably combined in settings with a high prevalence of both infections, results of…

Study to test efficacy of liposomal amphotericin for cryptococcal meningitis

Researchers plan to conduct a study examining whether a single high dose of liposomal amphotericin  with high-dose fluconazole and flucytosine is noninferior to a 7-day course of amphotericin B deoxycholate…

Even virally suppressed, people with HIV see faster brain atrophy after 60

That’s compared with a control group of HIV-negative individuals in a small study. Living with fully suppressed HIV is associated with faster brain atrophy in various regions compared with being…

Urokinase plasminogen receptor levels linked to non-AIDS related events during ART viral suppression

In patients with HIV, elevated levels of soluble urokinase plasminogen activator receptor are associated with non-AIDS events, according to study results published in Clinical Infectious Diseases. The study included participants with…

Air pollution may worsen brain function in HIV-infected children

The combination of air pollution and HIV infection may have a greater detrimental impact on the cognitive abilities of school-aged children than exposure to either factor alone, according to an…

Potential drug interactions among people with HIV taking statins

Drug interactions remain a potential problem for HIV-positive people who are treated with statins, according to research published in the December issue of the Journal of the American Heart Association. Potential…

‘Left behind’: Drug companies and researchers have overlooked patients who don’t respond to HIV meds

To look at Nelson Vergel, you would never guess what he has been through. For 35 years, he has kept up a relentless fight against HIV, but his muscular physique…

Imperial takes the lead on a global study of HIV-associated liver cancer

Research from the Liver Cancer Research Group at Imperial has shed new light on the natural course of liver cancer in people living with HIV. In a report recently published…

Cancer concerns in people with HIV

Researchers looked both at the first and second time people with HIV have been diagnosed with cancer. People with HIV are increasingly being diagnosed with a non-AIDS-defining cancer for a…

1 2 3 49